The Oxford–AstraZeneca COVID-19 vaccine-Phase Three Abstract

Finally, here it is!

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

https://www.nejm.org/doi/full/10.1056/NEJMoa2105290?

The Oxford–AstraZeneca COVID-19 vaccine, codenamed AZD1222, and sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for prevention of COVID-19